Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CCME bull's eye Fernando.
ALIF up 8% on 200.000 shares (The average is 60.000)
ALIF volume is increasing each day. From all the stocks I have, this one has the biggest potential long term IMHO
NIV anyone holding this one??
NIV might be starting a move at this point
BORN - a month ago, during the UTA case, this article would mean a 10% drop. But things do seem different now. Like you mentioned, HRBN could mean the game changer for china stocks.
CELM ai caramba! Congrats man, great timing!
DHRM + 15% Still cheap at present level.
DHRM + 7%. I think this time it might go all the way to 9 or 10.
DHRM + 19% Having a nice deja vu
Great trade congrats! I sold mine below present value...
DHRM + 18%
DHRM LOL
"Not until my $4.52 bid gets filled. LOL ........ "
DHRM any of you guys follows or holds this one?
DHRM will it start moving today? Sure hope so...
I've made some extensive DD on ALIF, and among all my holdings this stock is the one I believe will be the best performer in the near future.
I'm talking about a possible multi bagger...
This DD is in portuguese, but you guys can use the Google translator and see why I feel so confident about ALIF...
http://www.bullpowerinvest.com/alifob.html
CCME I believe you're right amigo.
Um abraço
CCME What a lovely hammer
ALIF good news
Artificial Life Selected by Microsoft as Showcase Partner to Develop Windows Phone 7 Games
Red Bull Racing Challenge Meets New Audience
Press Release Source: Artificial Life, Inc. On Wednesday October 6, 2010, 8:00 am EDT
HONG KONG, LOS ANGELES and BERLIN, Oct. 6, 2010 (GLOBE NEWSWIRE) -- Artificial Life, Inc. (OTCBB:ALIF - News) (http://www.artificial-life.com), a leading provider of award-winning mobile broadband technology and applications, today announced that its hit title: Red Bull Racing Challenge will be available on the Windows Phone 7 platform very soon. Artificial Life is one of the first mobile game publishers selected by Microsoft as part of the Showcase to bring titles to the new platform scheduled for this holiday season.
"We are excited to bring Red Bull Racing Challenge to Windows 7 devices. Artificial Life will take this opportunity to capture an even broader audience with the extension to Microsoft's Windows Phone 7 Platform," said Eberhard Schoneburg, CEO, Artificial Life, Inc.
PUDA strongest stock on my portfolio for the second straight day.
ZSTN I love the smell roasted shorts in the afternoon... :)
ZSTN up 11%
ZSTN Great timing man. Congrats.
SOKF - 38% on 113 shares
DHRM add a chunk today. To good to pass at this level.
Current Ratio: 3,09
Debt Equity Ratio: 38%
Cash: 6,54M
Book Value: 13,89M
Gross Margin: 39%
Net Margin: 24%
Outstnding Shares: 4,5M
Market Cap: 22,5M
DHRM starting a new position at this level. To tasty to pass...
Current Ratio: 3,09
Debt Equity Ratio: 38%
Cash: 6,54M
Book Value: 13,89M
Gross Margin: 39%
Net Margin: 24%
Outstnding Shares: 4,5M
Market Cap: 22,5M
Estimated EPS for 2010 of 0,80 | PER of 6
Like this guy wrote on SA: Think Healthcare Ahead of China's 12th Five-Year Plan http://seekingalpha.com/article/226336-think-healthcare-ahead-of-china-s-12th-five-year-plan?source=email
The health Industry in China seems like a good place to be invested in IMHO:
In April 2009, the Chinese government implemented large-scale healthcare reform. The State Council allocated $123 billion as part of its New Medical Reform Plan. The plan contemplates the development of a universal healthcare system that will cover 90% of China’s population by the end of 2010 and will provide health coverage for all Chinese by 2020.
Specifically, within three years, the Chinese government aims to improve the urban healthcare system by rebuilding and restructuring 3,700 existing urban community health centers and 11,000 community health clinics. The plan will also accommodate the development of 2,400 new urban health centers. In effect, the plan de-emphasizes the prevalence of large, magnet facilities in favor of smaller, more accessible clinics.
Dehaier Medical Systems is an emerging company in the development, assembly, marketing and sale of medical products in China, including respiratory and oxygen homecare products. The company develops and assembles its own branded products from third party components. The company also distributes products designed and manufactured by other companies including medical devices and respiratory and oxygen homecare products from IMD (Italy), Timesco (UK), ResMed (Australia), Welch Allyn (USA), HEYER (Germany), Penlon (U.K) and JMS (Japan).
Company Overview
DHRM offers a broad range of approximately 30 products used in surgeries, hospital rooms and at home. DHRM also provides technical services and support to manufacturers and distributors. In recent years, DHRM has placed significant emphasis on respiratory and oxygen homecare products. Through the integration of technology, customer input and employee creativity, DHRM seeks to provide innovative, high quality and affordable products that improve the lives of people with sleep and respiratory disorders.
The company sells the majority of its products through a network of over 2,000 independent distributors. DHRM also employs 70 direct sales and sales support personnel selling directly to end users such as hospitals, clinics, government health bureaus and individual customers.
Dehaier leverages its network of relationships with healthcare facilities and has broadened its market reach by introducing new and more advanced products and new product lines that address different end-user populations.
Industry
DHRM has 155 employees including 20 in R&D. The company’s technology is based on two patents, five pending patents and proprietary technology. DHRM maintains a 5,400 square foot research and development center in its facility in Beijing. In addition, the company is cooperating with research institutes at two top ranked Chinese universities: Beijing University of Aeronautics & Astronautics and Beijing University of Technology and Science.
In addition, the plan is designed to dramatically improve medical services available for the 800 million rural poor in China. Through the plan, the Chinese government contemplates the development of clinics in every village and a hospital in every county in China by the end of 2011. If successfully implemented, the plan would result in at least 2,000 new county-level hospitals and 29,000 township hospitals and the upgrading of another 5,000 more.
Differentiators
Branded and Distributed Medical Devices
DHRM derives revenues from the sale of C-arm X-ray systems, anesthesia machines, patient monitors and general hospital products. The medical device segment is the company's largest business line of products and has the most extensive market penetration of its three product lines. DHRM anticipates continued revenue growth in its medical device product line as it further penetrates the market through developing and introducing advanced new product offerings.
Respiratory and Oxygen Homecare Products
DHRM derives revenues from sales of oxygen concentrators, CPAP devices, portable sleep screening and diagnostic devices and thermotherapy products. DHRM anticipates continued revenue growth from respiratory and oxygen homecare as new and more advanced products in this line are introduced. DHRM expects to increase distribution in China’s respiratory and oxygen homecare market as well as growing sales in international markets through use of distributors as well as through its direct sales platform.
Branded Technical Services
DHRM derives revenues from sales of air compressors and ventilator trolleys. DHRM anticipates continued growth in revenues from technical service products as they further penetrate this market by increasing the number of their distributors and maintaining a competitive pricing model.
Competitive Strengths
Established brand and market position in China’s medical products and respiratory and oxygen homecare industries
Established distribution, sales and service network throughout China
Strong research and development capabilities
Established relationships with foreign medical device manufacturers
Established relationships with hospital customers
Dedicated customer support and service
Recent News
8/16/10-Dehaier Medical Systems Q2 Revenue Up 46% to $4.83 Million; Net Income Up 59% to $1.14 Million; EPS $0.278/12/10-Dehaier Medical Systems Schedules Second Quarter 2010 Earnings Release and Conference Call8/11/10-Dehaier Medical Systems To Exhibit in International Medical Products Tradeshow FIME 2010 in Miami, Florida7/13/10-Dehaier Medical Systems Acquires Emergency Ventilator Series to Extend Product Line7/06/10-Dehaier Medical Systems Reaffirms Earnings Estimate of $0.80 EPS for FY 2010
Risk Factors
Uncertain trading volume following IPO
China’s healthcare-related government policies
Acceptance level of DHRM products among hospitals and other healthcare facilities
Ability to attract and retain distributors, key customers and direct sales force
China’s competitive environment
The Outlook
DHRM is positioned to benefit from the surging growth of expenditures on medical products in China and the growing demand for domestic medical products. A recent article published by the Wharton School (Univ. of Pennsylvania) suggests that China’s medical products market will reach $28 billion by 2014. This market was valued at $12.14 billion in 2008, representing roughly one-eighth of China’s overall healthcare market.
China’s medical products market is projected to grow faster than the global medical market. China is already the third largest medical products market in the world behind the United States and Japan. Within five to seven years it is expected to surpass Japan to become the world’s second largest medical products market. Market growth rates for 2009 are projected at 11.2%.
DHRM’s strategy is to strengthen its position as one of China’s leaders in developing, assembling and marketing respiratory and oxygen homecare products and to develop a presence in select foreign markets including Europe and America.
KNDI absolutely. IMO he knows the company better than the BOD LOL
KNDI Great move +14%...Nice...
Excelente meu amigo!
CSGH up 20%
I just came to my PC and CCME is up 14% on 24.000 shares? What happend man?
ZSTN I have fasten my seatbelt...
LOL Can't complain. You were the one who presented me to BORN.Obrigado amigo.
I feel like having a glass of baiju. hehe
Great info Rames. Thanks. I will definitely watch for those signals.
Good luck!
Thanks Rames. I own BORN as well. The chinese IPO stocks seem to be dancing at a different music (I don't know if this portuguese saying makes any sense in english LOL)
DHRM here we go again :)
CCME You should sue yourself for your email.
Ah, wait... your lawyers need to take care of SIAF first..
DHRM Kabooooom + 25%
Thanks Rato. We might get near the IPO value soon, depending on The general markets...
Um abraço meu amigo!
DHRM Thanks Bob. Man, my hands are shaking. 50% in 2 days...:D
Still has upside potential though...